Cargando…

Identification of Autoantibodies to a Hybrid Insulin Peptide in Type 1 Diabetes

Type 1 diabetes (T1D) is a chronic autoimmune disease that attacks the insulin-producing b cells of the pancreatic islets. Autoantibodies to b cell proteins typically appear in the circulation years before disease onset, and serve as the most accurate biomarkers of T1D risk. Our laboratory has recen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wenzlau, Janet M., Gu, Yong, Michels, Aaron, Rewers, Marian, Haskins, Kathryn, Yu, Liping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487141/ https://www.ncbi.nlm.nih.gov/pubmed/37685398 http://dx.doi.org/10.3390/diagnostics13172859

Ejemplares similares

Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes
por: Baker, Rocky L., et al.
Publicado: (2019)

Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetes
por: Wenzlau, Janet M., et al.
Publicado: (2022)

Extrapancreatic Autoantibody Profiles in Type I Diabetes
por: Burbelo, Peter D., et al.
Publicado: (2012)

High-throughput multiplexed autoantibody detection to screen type 1 diabetes and multiple autoimmune diseases simultaneously
por: Gu, Yong, et al.
Publicado: (2019)

Distinguishing Persistent Insulin Autoantibodies With Differential Risk: Nonradioactive Bivalent Proinsulin/Insulin Autoantibody Assay
por: Yu, Liping, et al.
Publicado: (2012)

Age of Islet Autoantibody Appearance and Mean Levels of Insulin, but Not GAD or IA-2 Autoantibodies, Predict Age of Diagnosis of Type 1 Diabetes: Diabetes Autoimmunity Study in the Young
por: Steck, Andrea K., et al.
Publicado: (2011)

Changes in Zinc Transporter 8 Autoantibodies Following Type 1 Diabetes Onset: The Type 1 Diabetes Genetics Consortium Autoantibody Workshop
por: Wenzlau, Janet M., et al.
Publicado: (2015)

Proinsulin/Insulin Autoantibodies Measured With Electrochemiluminescent Assay Are the Earliest Indicator of Prediabetic Islet Autoimmunity
por: Yu, Liping, et al.
Publicado: (2013)

Induction of Antigen-Specific Tolerance in Autoimmune Diabetes with Nanoparticles Containing Hybrid Insulin Peptides
por: DiLisio, James E., et al.
Publicado: (2021)

Zinc Transporter-8 Autoantibodies Improve Prediction of Type 1 Diabetes in Relatives Positive for the Standard Biochemical Autoantibodies
por: Yu, Liping, et al.
Publicado: (2012)

GAD65 Autoantibodies Detected by Electrochemiluminescence Assay Identify High Risk for Type 1 Diabetes
por: Miao, Dongmei, et al.
Publicado: (2013)

Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes
por: Demeester, Simke, et al.
Publicado: (2015)

High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes
por: Jia, Xiaofan, et al.
Publicado: (2021)

Novel Association Between Immune-Mediated Susceptibility Loci and Persistent Autoantibody Positivity in Type 1 Diabetes
por: Brorsson, Caroline A., et al.
Publicado: (2015)

A Common Nonsynonymous Single Nucleotide Polymorphism in the SLC30A8 Gene Determines ZnT8 Autoantibody Specificity in Type 1 Diabetes
por: Wenzlau, Janet M., et al.
Publicado: (2008)

Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY)
por: Waugh, Kathleen, et al.
Publicado: (2017)

Higher Sensitivity and Earlier Identification of Celiac Disease Autoimmunity by a Nonradioactive Assay for Transglutaminase Autoantibodies
por: Zhao, Zhiyuan, et al.
Publicado: (2016)

Early Diabetic Nephropathy: A complication of reduced insulin sensitivity in type 1 diabetes
por: Bjornstad, Petter, et al.
Publicado: (2013)

Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes
por: Gu, Yong, et al.
Publicado: (2021)

Characterization of Human CD4 T Cells Specific for a C-Peptide/C-Peptide Hybrid Insulin Peptide
por: Wiles, Timothy A., et al.
Publicado: (2021)

Increased Effector Memory Insulin-Specific CD4(+) T Cells Correlate With Insulin Autoantibodies in Patients With Recent-Onset Type 1 Diabetes
por: Spanier, Justin A., et al.
Publicado: (2017)

No Relation Between Cystic Fibrosis–Related Diabetes and Type 1 Diabetes Autoimmunity
por: Gottlieb, Peter A., et al.
Publicado: (2012)

Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes
por: Strollo, Rocky, et al.
Publicado: (2022)

Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases
por: Howson, J. M. M., et al.
Publicado: (2012)

Identifying New Hybrid Insulin Peptides (HIPs) in Type 1 Diabetes
por: Mannering, Stuart I., et al.
Publicado: (2021)

Insulin Resistance, Defective Insulin-Mediated Fatty Acid Suppression, and Coronary Artery Calcification in Subjects With and Without Type 1 Diabetes: The CACTI Study
por: Schauer, Irene E., et al.
Publicado: (2011)

Challenges in Diagnosing Type 1 Diabetes in Different Populations
por: Rewers, Marian
Publicado: (2012)

Hybrid Insulin Peptides Are Recognized by Human T Cells in the Context of DRB1*04:01
por: Arribas-Layton, David, et al.
Publicado: (2020)

Hybrid insulin peptide isomers spontaneously form in pancreatic beta-cells from an aspartic anhydride intermediate
por: Crawford, Samantha A., et al.
Publicado: (2023)

The Influence of Type 1 Diabetes Genetic Susceptibility Regions, Age, Sex, and Family History on the Progression From Multiple Autoantibodies to Type 1 Diabetes: A TEDDY Study Report
por: Krischer, Jeffrey P., et al.
Publicado: (2017)

Insulin Resistance, β-Cell Dysfunction, and Conversion to Type 2 Diabetes in a Multiethnic Population: The Insulin Resistance Atherosclerosis Study
por: Lorenzo, Carlos, et al.
Publicado: (2010)

Lipoprotein Subfraction Cholesterol Distribution Is Proatherogenic in Women With Type 1 Diabetes and Insulin Resistance
por: Maahs, David M., et al.
Publicado: (2010)

C-Peptide-Positive, Autoantibody-Negative Type 1 Diabetes Mellitus
por: Fenner, Rachel M, et al.
Publicado: (2022)

Role of Type 1 Diabetes–Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study
por: Törn, Carina, et al.
Publicado: (2015)

HLA-A*24 Is an Independent Predictor of 5-Year Progression to Diabetes in Autoantibody-Positive First-Degree Relatives of Type 1 Diabetic Patients
por: Mbunwe, Eric, et al.
Publicado: (2013)

Identification of Autoantibody-Negative Autoimmune Type 2 Diabetic Patients
por: Brooks-Worrell, Barbara M., et al.
Publicado: (2011)

Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Human trials and a look into the future
por: Rewers, Marian, et al.
Publicado: (2009)

Insulin Gene Mutations as Cause of Diabetes in Children Negative for Five Type 1 Diabetes Autoantibodies
por: Bonfanti, Riccardo, et al.
Publicado: (2009)

The Prediction of Type 1 Diabetes by Multiple Autoantibody Levels and Their Incorporation Into an Autoantibody Risk Score in Relatives of Type 1 Diabetic Patients
por: Sosenko, Jay M., et al.
Publicado: (2013)

Pathogenesis of type 1 diabetes: lessons from natural history studies of high-risk individuals
por: Nokoff, Natalie, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_tbqlg67445gtu6ifva4pecus3t